Neurodegenerative diseases-Caps: a capsule network based early screening system for the classification of neurodegenerative diseases

被引:0
作者
Kirti Raj Bhatele
Anand Jha
Kavish Kapoor
Devanshu Tiwari
机构
[1] RJIT,
[2] BSF Academy,undefined
[3] Kavlabs,undefined
[4] RGPV,undefined
来源
Cognitive Neurodynamics | 2022年 / 16卷
关键词
Neurodegenerative diseases; Parkinson; Alzheimer; Capsule network; ResNet50; VGG 16; VGG 19; InceptionV3 etc.;
D O I
暂无
中图分类号
学科分类号
摘要
The two most generally diagnosed Neurodegenerative diseases are the Alzheimer and Parkinson diseases. So this paper presents a fully automated early screening system based on the Capsule network for the classification of these two Neurodegenerative diseases. In this study, we hypothesized that the Neurodegenerative diseases-Caps system based on the Capsule network architecture accurately performs the multiclass i.e. three class classification into either the Alzheimer class or Parkinson class or Healthy control and delivers better results in comparison other deep transfer learning models. The real motivation behind choosing the capsule network architecture is its more resilient nature towards the affine transformations as well as rotational & translational invariance, which commonly persists in the medical image datasets. Apart from this, the capsule networks overcomes the pooling layers related deficiencies from which conventional CNNs are mostly affected and unable to delivers accurate results especially in the tasks related to image classification. The various Computer aided systems based on machine learning for the classification of brain tumors and other types of cancers are already available. Whereas for the classification of Neurodegenerative diseases, the amount of research done is very limited and the number of persons suffering from this type of diseases are increasing especially in developing countries like India, China etc. So there is a need to develop an early screening system for the correct multiclass classification into Alzheimer’s, Parkinson’s and Normal or Healthy control cases. The Alzheimer disease and Parkinson progression (ADPP) dataset is used in this research study for the training of the proposed Neurodegenerative diseases-Caps system. This ADPP dataset is developed with the aid of both the Parkinson's Progression Markers Initiative (PPMI) and Alzheimer’s disease Neuroimaging Initiative (ADNI) databases. There is no such early screening system exist yet, which can perform the accurate classification of these two Neurodegenerative diseases. For the sake of genuine comparison, other popular deep transfer learning models like VGG19, VGG16, ResNet50 and InceptionV3 are implemented and also trained over the same ADPP dataset. The proposed Neurodegenerative diseases-Caps system deliver accuracies of 97.81, 98, 96.81% for the Alzheimer, Parkinson and Healthy control or Normal cases with 70/30 (training/validation split) and performs way better as compare to the other popular Deep transfer learning models.
引用
收藏
页码:1361 / 1377
页数:16
相关论文
共 50 条
  • [31] Preclinical Nanomedicines for Polyglutamine-Based Neurodegenerative Diseases
    Lee, Leo Kit Cheung
    Leong, Lok, I
    Liu, Yao
    Luo, Meihua
    Chan, Ho Yin Edwin
    Choi, Chung Hang Jonathan
    MOLECULAR PHARMACEUTICS, 2021, 18 (02) : 610 - 626
  • [32] Advancements in PROTAC-based therapies for neurodegenerative diseases
    Kong, Deyuan
    Meng, Liying
    Lin, Pengfei
    Wu, Guanzhao
    FUTURE MEDICINAL CHEMISTRY, 2025, 17 (05) : 591 - 605
  • [33] A frontline defense against neurodegenerative diseases:the development of early disease detection methods
    Baldacci, Filippo
    Lista, Simone
    Vergallo, Andrea
    Palermo, Giovanni
    Giorgi, Filippo Sean
    Hampel, Harald
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (07) : 559 - 563
  • [34] Extracellular vesicles-based theranostics for neurodegenerative diseases
    Zhao, Han
    Zhu, Ling
    Wang, Chen
    Yang, Yanlian
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2024, 16 (05)
  • [35] Metal-Based Therapeutic Strategies of Neurodegenerative Diseases
    Zhang Shibing
    Wang Ying
    Liu Changlin
    PROGRESS IN CHEMISTRY, 2009, 21 (05) : 903 - 910
  • [36] Classification of neurodegenerative diseases using gait dynamics via deterministic learning
    Zeng, Wei
    Wang, Cong
    INFORMATION SCIENCES, 2015, 317 : 246 - 258
  • [37] Uncovering the Pharmacological Mechanism of Stemazole in the Treatment of Neurodegenerative Diseases Based on a Network Pharmacology Approach
    Zhang, Jing
    Li, Huajun
    Zhang, Yubo
    Zhao, Chaoran
    Zhu, Yizi
    Han, Mei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (02)
  • [38] The ubiquitin proteasome system in neurodegenerative diseases: Culprit, accomplice or victim?
    Dennissen, F. J. A.
    Kholod, N.
    van Leeuwen, F. W.
    PROGRESS IN NEUROBIOLOGY, 2012, 96 (02) : 190 - 207
  • [39] The ubiquitin proteasome system in glia and its role in neurodegenerative diseases
    Jansen, Anne H. P.
    Reits, Eric A. J.
    Hol, Elly M.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2014, 7
  • [40] Apelin/APJ system: A novel promising target for neurodegenerative diseases
    Luo, Huaiqing
    Han, Li
    Xu, Jin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (02) : 638 - 657